Do we have to operate on moderate functional mitral regurgitation during aortic valve replacement for aortic

Adam R Kowalówka1, Magdalena Onyszczuk2, Wojciech Wańha3

  • 1Department of Cardiac Surgery, Medical University of Silesia, School of Medicine in Katowice, Katowice, Poland adam.kowalowka@orange.pl.

Insights

For moderate functional mitral regurgitation during aortic valve replacement for aortic stenosis, conservative treatment is often effective. Surgery is recommended for moderate-severe or severe cases, especially with deterioration predictors.

Area of Science:

  • Cardiac Surgery
  • Cardiology
  • Clinical Evidence Synthesis

Background:

  • A best evidence topic addressed whether to operate on moderate functional mitral regurgitation (FMR) during aortic valve replacement (AVR) for aortic stenosis (AS).
  • A systematic search identified 325 papers, with 9 selected for best evidence analysis.
  • The study aimed to clarify surgical strategies for FMR in patients undergoing AVR for AS.

Observation:

  • Significant predictors of improved outcomes included lower preoperative mitral regurgitation and better left ventricle fractional area change.
  • Predictors of deterioration included persistent atrial fibrillation, enlarged left atrium, increased left ventricular mass, pulmonary hypertension, and a peak aortic valve gradient <60 mmHg.
  • A general trend showed improvement or non-progression of FMR after AVR for AS.

Findings:

  • Conservative management of FMR showed improvement in 45-95% of cases, with 19-38% unchanged and 1-14% deterioration.
  • Surgical treatment of FMR resulted in improvement in 46-69%, 34-53% unchanged, and 10% deterioration.
  • Moderate or less FMR without deterioration predictors can be treated conservatively; moderate-severe and severe FMR warrant surgical intervention.

Implications:

  • Current evidence supports conservative management for moderate FMR without adverse predictors during AVR for AS.
  • Surgical intervention for FMR is advised for moderate-severe and severe cases, particularly those with identified deterioration risks.
  • Further randomized controlled trials are needed to definitively guide surgical strategies for FMR in AS patients.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
540
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
510
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.1K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
423
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
819
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
485